Previous close | 3.5400 |
Open | 3.4900 |
Bid | 2.8500 |
Ask | 3.6000 |
Strike | 7.50 |
Expiry date | 2025-01-17 |
Day's range | 3.4900 - 3.5400 |
Contract range | N/A |
Volume | |
Open interest | 1 |
Healthy transplanted human glial cells replaced diseased glial cells in the brains of human glial chimeric Huntingtin mice Additional proof-of-concept for the advancement of SC379, Sana’s pluripotent stem cell-derived glial progenitor cell product candidate SEATTLE, May 21, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today highlighted that Nature Biotechnology has published a paper titled “You
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
Aligns with Analyst Projections Amidst Strategic Clinical Advancements